Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × umbralisib × Clear all

NCT02874404 2023-10-05

TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 2 Completed

13 enrolled 10 charts

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02793583 2022-07-21

UNITY-NHL

Phase 2/3 Terminated

710 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell